3. Sustainability & Transformation Plans: ‘STPs’
Help develop, and achieve progress vs delivery of, high-quality STPs – rooted in delivery of
the 5YFV
Return provider sector to aggregate financial balance
Improved financial position for all individual trusts compared to 15/16
Aggregate break-even position for provider sector
Deliver, or achieve recovery trajectory milestones towards, key access & NHS
constitution standards
Access standards for A&E and ambulance waits
NHS Constitution standards for 18-week RTT and 62-day cancer waits
Achieve and maintain the mental health and dementia diagnosis, referral, treatment
Improve & maintain quality and safety for patients
Robust, affordable plan in place for achieving, and/or maintaining, ‘Good’ or ‘Outstanding’
CQC ratings
Must publish annual avoidable mortality rates; and address challenges under 7-day services
2016/17: key ‘must dos’ for NHST’s & NHS FTs
4. = £8.4 billion real terms increase for the
NHS by 2020/21, front-loaded…
Although challenges remain, this provides a credible
basis on which to accomplish three interdependent
tasks:
1. implement the Five Year Forward View
(closing health, quality and finance gaps);
2. restore and maintain financial balance; and
3. deliver core access and quality standards for
patients.
In 2016/17,there is an additional £5.4bnfor health;
£3.5bn in CCG allocations and£1.8bnSustainability and
Transformation Fund
Spending Review Settlement
5. The last two days had proved that this programme supports
• Patient safety
• Regulatory Compliance
• Operational Efficiency and Financial Control
How do we implement if we are not a demonstrator site?
• We haven’t got any money
• We haven’t got a clinical champion or have run out of them
• “We are all doomed” and have given up
Sensibly assess your barriers to implementation (and your readiness assessment) and
discuss how to best make incremental steps on the journey to policy compliance, and go and
flagrantly steal ideas from the demonstrator sites.
GS1 to deliver to this agenda
6. Patient Safety Benefits shown:
• In theatre – reducing risk of never events
• In certainty of who did what to whom, when, where, with what and why
• In reducing re-dos
Regulatory Compliance benefits discussed:
• Improved recall processes
• Elimination of counterfeit medicines
Financial control benefits:
• Right stock in the right place at the right time, minimising inventory
• Certainty about what we bought, what we lost, what it cost
• Best value products / outcomes based
• Moves us from ‘think’ and ‘hope’, to ‘know’ and ‘control’
The benefits of GS1
7. Joint working:
DH – Ministerial Support, National infrastructure investment and programme funding
NHS Improvement – What implementation support do you need?
Suppliers & Technology Providers – Support
This programme is here to stay, and will not go away.
The economic benefits are becoming very clear, the patient safety benefits are obvious
– it’s not a case of can you afford the time to implement, more can you afford not to?
Concluding remarks